vs

Side-by-side financial comparison of Coursera, Inc. (COUR) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.

iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $196.9M, roughly 1.1× Coursera, Inc.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -13.6%, a 16.3% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 9.9%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $5.4M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 7.9%).

Coursera Inc. is an American for-profit online university, earlier operating as a global massive open online course provider from 2012 until 2021. It was founded in 2012 by Stanford University computer science professors Andrew Ng and Daphne Koller. Coursera works with universities and other organizations to offer online courses, certifications, and degrees in a variety of subjects.

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

COUR vs IRTC — Head-to-Head

Bigger by revenue
IRTC
IRTC
1.1× larger
IRTC
$208.9M
$196.9M
COUR
Growing faster (revenue YoY)
IRTC
IRTC
+17.2% gap
IRTC
27.1%
9.9%
COUR
Higher net margin
IRTC
IRTC
16.3% more per $
IRTC
2.7%
-13.6%
COUR
More free cash flow
IRTC
IRTC
$9.1M more FCF
IRTC
$14.5M
$5.4M
COUR
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
7.9%
COUR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COUR
COUR
IRTC
IRTC
Revenue
$196.9M
$208.9M
Net Profit
$-26.8M
$5.6M
Gross Margin
54.2%
70.9%
Operating Margin
-16.4%
1.1%
Net Margin
-13.6%
2.7%
Revenue YoY
9.9%
27.1%
Net Profit YoY
-24.1%
518.5%
EPS (diluted)
$-0.16
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COUR
COUR
IRTC
IRTC
Q4 25
$196.9M
$208.9M
Q3 25
$194.2M
$192.9M
Q2 25
$187.1M
$186.7M
Q1 25
$179.3M
$158.7M
Q4 24
$179.2M
$164.3M
Q3 24
$176.1M
$147.5M
Q2 24
$170.3M
$148.0M
Q1 24
$169.1M
$131.9M
Net Profit
COUR
COUR
IRTC
IRTC
Q4 25
$-26.8M
$5.6M
Q3 25
$-8.6M
$-5.2M
Q2 25
$-7.8M
$-14.2M
Q1 25
$-7.8M
$-30.7M
Q4 24
$-21.6M
$-1.3M
Q3 24
$-13.7M
$-46.2M
Q2 24
$-22.9M
$-20.1M
Q1 24
$-21.3M
$-45.7M
Gross Margin
COUR
COUR
IRTC
IRTC
Q4 25
54.2%
70.9%
Q3 25
54.6%
71.1%
Q2 25
54.9%
71.2%
Q1 25
54.6%
68.8%
Q4 24
53.3%
70.0%
Q3 24
54.6%
68.8%
Q2 24
53.0%
69.9%
Q1 24
52.9%
66.3%
Operating Margin
COUR
COUR
IRTC
IRTC
Q4 25
-16.4%
1.1%
Q3 25
-8.0%
-4.4%
Q2 25
-8.1%
-10.0%
Q1 25
-8.0%
-20.5%
Q4 24
-17.0%
-2.5%
Q3 24
-12.3%
-34.1%
Q2 24
-18.3%
-15.5%
Q1 24
-17.6%
-28.9%
Net Margin
COUR
COUR
IRTC
IRTC
Q4 25
-13.6%
2.7%
Q3 25
-4.4%
-2.7%
Q2 25
-4.2%
-7.6%
Q1 25
-4.4%
-19.3%
Q4 24
-12.1%
-0.8%
Q3 24
-7.8%
-31.3%
Q2 24
-13.4%
-13.6%
Q1 24
-12.6%
-34.6%
EPS (diluted)
COUR
COUR
IRTC
IRTC
Q4 25
$-0.16
$0.18
Q3 25
$-0.05
$-0.16
Q2 25
$-0.05
$-0.44
Q1 25
$-0.05
$-0.97
Q4 24
$-0.13
$-0.03
Q3 24
$-0.09
$-1.48
Q2 24
$-0.15
$-0.65
Q1 24
$-0.14
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COUR
COUR
IRTC
IRTC
Cash + ST InvestmentsLiquidity on hand
$792.6M
$583.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$635.7M
$152.7M
Total Assets
$1.0B
$1.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COUR
COUR
IRTC
IRTC
Q4 25
$792.6M
$583.8M
Q3 25
$797.7M
$565.2M
Q2 25
$775.1M
$545.5M
Q1 25
$748.0M
$520.6M
Q4 24
$726.1M
$535.6M
Q3 24
$719.4M
$522.0M
Q2 24
$708.8M
$561.5M
Q1 24
$725.4M
$569.1M
Stockholders' Equity
COUR
COUR
IRTC
IRTC
Q4 25
$635.7M
$152.7M
Q3 25
$639.5M
$121.9M
Q2 25
$627.0M
$103.7M
Q1 25
$610.5M
$86.7M
Q4 24
$597.4M
$90.9M
Q3 24
$593.3M
$71.8M
Q2 24
$585.2M
$99.2M
Q1 24
$609.1M
$90.3M
Total Assets
COUR
COUR
IRTC
IRTC
Q4 25
$1.0B
$1.0B
Q3 25
$995.3M
$995.2M
Q2 25
$979.9M
$964.0M
Q1 25
$951.2M
$926.1M
Q4 24
$930.3M
$931.4M
Q3 24
$914.1M
$909.7M
Q2 24
$904.4M
$919.2M
Q1 24
$916.3M
$909.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COUR
COUR
IRTC
IRTC
Operating Cash FlowLast quarter
$5.8M
$26.2M
Free Cash FlowOCF − Capex
$5.4M
$14.5M
FCF MarginFCF / Revenue
2.7%
6.9%
Capex IntensityCapex / Revenue
0.2%
5.6%
Cash ConversionOCF / Net Profit
4.70×
TTM Free Cash FlowTrailing 4 quarters
$107.2M
$34.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COUR
COUR
IRTC
IRTC
Q4 25
$5.8M
$26.2M
Q3 25
$33.9M
$34.9M
Q2 25
$35.5M
$27.7M
Q1 25
$33.5M
$-7.9M
Q4 24
$19.2M
$19.2M
Q3 24
$27.9M
$24.3M
Q2 24
$23.8M
$11.8M
Q1 24
$24.5M
$-52.0M
Free Cash Flow
COUR
COUR
IRTC
IRTC
Q4 25
$5.4M
$14.5M
Q3 25
$33.7M
$20.1M
Q2 25
$35.1M
$17.3M
Q1 25
$33.0M
$-17.3M
Q4 24
$18.1M
$12.4M
Q3 24
$27.7M
$15.5M
Q2 24
$23.6M
$3.4M
Q1 24
$24.4M
$-61.8M
FCF Margin
COUR
COUR
IRTC
IRTC
Q4 25
2.7%
6.9%
Q3 25
17.4%
10.4%
Q2 25
18.8%
9.3%
Q1 25
18.4%
-10.9%
Q4 24
10.1%
7.5%
Q3 24
15.7%
10.5%
Q2 24
13.9%
2.3%
Q1 24
14.4%
-46.8%
Capex Intensity
COUR
COUR
IRTC
IRTC
Q4 25
0.2%
5.6%
Q3 25
0.1%
7.7%
Q2 25
0.2%
5.6%
Q1 25
0.3%
5.9%
Q4 24
0.6%
4.2%
Q3 24
0.1%
6.0%
Q2 24
0.1%
5.7%
Q1 24
0.1%
7.4%
Cash Conversion
COUR
COUR
IRTC
IRTC
Q4 25
4.70×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COUR
COUR

Consumer Segment$131.5M67%
Enterprise Segment$65.4M33%

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

Related Comparisons